DOSE DETERMINATION OF RADIOACTIVE IODINE IN TREATMENT OF HYPERTHYROIDISM UTILIZING QUANTITATIVE 99MTC-PERTECHNETATE THYROID SPECT/CT

Received 2022-01-27; Accepted 2022-10-12; Published 2022-12-31

Authors

  • Muhammad Adib Abdul Onny Department of Nuclear Medicine, Radiotherapy and Oncology, School of Medical Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia
  • Syed Ejaz Shamim Hospital Universiti Putra Malaysia, Persiaran Mardi, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia
  • Mohd Syahir Mansor Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, 13200, Kepala Batas, Pulau Pinang, Malaysia
  • Hazlin Hashim Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, 13200, Kepala Batas, Pulau Pinang, Malaysia

DOI:

https://doi.org/10.22452/jummec.sp2022no1.15

Abstract

The aim is to evaluate the usefulness of technetium pertechnetate (99mTc) thyroid uptake (TcTU) obtained from thyroid scintigraphy using quantitative Single Photon Emission Computed Tomography / Computed Tomography (SPECT/CT) in determining personalised dose of 131I radioactive iodine (RAI) therapy for hyperthyroidism. A study of 131 participants with hyperthyroidism referred for RAI therapy was performed. 66 participants were enrolled into the prospective (calculated dose) group whereas 65 participants were from retrospective control (fixed dose) group. Quantitative thyroid SPECT/CT was performed for the prospective group prior to receiving RAI. TcTU and thyroid gland volume obtained from the Quantitative thyroid SPECT/CT were incorporated into modified Marinelli formula for RAI dose. Outcome of RAI was determined at the end of 6 months follow-up. Descriptive analysis of demographics and regression analyses of variables were performed. Mean calculated RAI dose was 17.74 mCi (SD 6.27) with mean dose for successful RAI at 6 months was 16.42 mCi (SD 5.87). Success rate was 80.3 % in the calculated group, versus 60.0 % in the fixed dose group (p-value 0.013). Regression analysis showed thyroid gland volume as an independent factor in determining successful outcome (adjusted OR = 0.963 CI: 0.942, 0.985) with volume of <77.2 ml more likely to produce successful outcome; sensitivity and specificity of 69 % and 83 % respectively. Quantitative SPECT/CT is useful in determining personalised dose of 131I RAI therapy. It significantly improves treatment outcome for hyperthyroidism as compared to the conventional fixed dose method.

Downloads

Download data is not yet available.
Globally, the prevalence of both communicable and non-communicable diseases has reached pandemic levels. The prevalence of diseases including type 2 diabetes, hypertension, and obesity is worldwide. With the help of technology, many of the most severe infectious diseases of the 20th century may now be fought. These disorders are conditions that develop over an extended period of time as a result of a combination of genetic, physiological, environmental, and behavioural factors, especially the non-communicable diseases. The goal of this Special Issue, "Combating disease: Current trends, risk, treatment and prevention" is to discuss a wide range of disease-related topics, including make studies about the current pandemic season public. We specially encourage articles that offer fresh perspectives on medicine, medical systems, and management including epidemiological studies, basic science of local and systemic responses related to the medical sciences, fundamental research in medical sciences in lowering risk, improving treatment and prevention. All Special issues of JUMMEC follow the exact peer review process as regular papers and are published along with the regular issues of the journal when they are accepted. There are additionally labelled as belonging to a Special Issue and share a particular topic of interest to the scientific community.

Downloads

Published

2022-12-31

Issue

Special Issue 1 (2022) Combating disease: Current trends, risk, treatment and prevention

Section

Research article

License

All authors agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0 to allow others to freely access, copy and use research provided the author is correctly attributed, unless otherwise stated. All articles are available online without charge or other barriers to access. However, anyone wishing to reproduce large quantities of an article (250+) should inform the publisher. Any opinion expressed in the articles are those of the authors and do not reflect that of the University of Malaya, 50603 Kuala Lumpur, Malaysia. 

Most read articles by the same author(s)